Search research articles
Contact Us
Filters
Showing results (271-280 of 296) with videos related to
Page
of 30
Sort By:
Translational Vision Science & Technology
|
September 26, 2025
Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR Report
Lukas Schloesser, Jan H Terheyden, Charlotte Behning, et al.
JAMA Ophthalmology
|
June 23, 2022
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report
Hannah M P Dunbar, Charlotte Behning, Amina Abdirahman, et al.
BMJ Open Ophthalmology
|
January 20, 2022
Incidence, progression and risk factors of age-related macular degeneration in 35-95-year-old individuals from three jointly designed German cohort studies
Caroline Brandl, Felix Günther, Martina E Zimmermann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
August 29, 2020
[Artificial intelligence in ophthalmology : Guidelines for physicians for the critical evaluation of studies]
Maximilian Pfau, Guenther Walther, Leon von der Emde, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
August 29, 2018
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration
Robert P Finger, Steffen Schmitz-Valckenberg, Matthias Schmid, et al.
Translational Vision Science & Technology
|
July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report
Bethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
The British Journal of Ophthalmology
|
June 8, 2026
Subretinal drusenoid deposits (reticular pseudodrusen) in the general population: a European multicohort study
Matthias M Mauschitz, Frank G Holz, Alexander K Schuster, et al.
Trials
|
July 20, 2020
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR
Jan H Terheyden, Frank G Holz, Steffen Schmitz-Valckenberg, et al.
Ophthalmology Science
|
February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
Robyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
BMC Medical Research Methodology
|
March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study
Jan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 296) with videos related to
Sort By:
Page
of 30
Translational Vision Science & Technology
|
September 26, 2025
Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR Report
Lukas Schloesser, Jan H Terheyden, Charlotte Behning, et al.
JAMA Ophthalmology
|
June 23, 2022
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report
Hannah M P Dunbar, Charlotte Behning, Amina Abdirahman, et al.
BMJ Open Ophthalmology
|
January 20, 2022
Incidence, progression and risk factors of age-related macular degeneration in 35-95-year-old individuals from three jointly designed German cohort studies
Caroline Brandl, Felix Günther, Martina E Zimmermann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
August 29, 2020
[Artificial intelligence in ophthalmology : Guidelines for physicians for the critical evaluation of studies]
Maximilian Pfau, Guenther Walther, Leon von der Emde, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
August 29, 2018
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration
Robert P Finger, Steffen Schmitz-Valckenberg, Matthias Schmid, et al.
Translational Vision Science & Technology
|
July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report
Bethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
The British Journal of Ophthalmology
|
June 8, 2026
Subretinal drusenoid deposits (reticular pseudodrusen) in the general population: a European multicohort study
Matthias M Mauschitz, Frank G Holz, Alexander K Schuster, et al.
Trials
|
July 20, 2020
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR
Jan H Terheyden, Frank G Holz, Steffen Schmitz-Valckenberg, et al.
Ophthalmology Science
|
February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
Robyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
BMC Medical Research Methodology
|
March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study
Jan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Page
of 30